Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
Saved in:
Published in | Cardiovascular diabetology Vol. 23; no. 1; pp. 103 - 2 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
18.03.2024
BMC |
Online Access | Get full text |
Cover
Loading…
Bibliography: | correction ObjectType-Correction/Retraction-1 SourceType-Scholarly Journals-1 content type line 14 content type line 23 |
---|---|
ISSN: | 1475-2840 1475-2840 |
DOI: | 10.1186/s12933-024-02190-6 |